AAV2-GDNF is a gene therapy that delivers GDNF (glial cell line-derived neurotrophic factor) agonists to enhance neuron survival and regeneration, particularly for dopamine-producing neurons, aiming to slow disease progression.
Discover our Products
Science-based and high-quality devices
